Literature DB >> 27402218

Clinicopathologic and radiologic features of extraskeletal myxoid chondrosarcoma: a retrospective study of 40 Chinese cases with literature review.

Rui Shao1, I Weng Lao2, Lei Wang2, Lin Yu2, Jian Wang3, Qinhe Fan4.   

Abstract

The aim of this study is to describe the clinicopathologic and radiologic features of 40 cases of extraskeletal myxoid chondrosarcoma (EMC) from China. There were 25 males and 15 females (sex ratio, 1.7:1). Apart from an adolescent, all patients were adults with a median age of 49years. Twenty-four tumors (60%) occurred in the lower limb and limb girdles, especially the thigh, followed by the upper limb and limb girdles (20%) and trunk (10%). Other less commonly involved locations included the head and neck, sacrococcygeal region, and perineum. Tumors ranged in size from 1.5 to 19cm (mean, 7cm). By radiology, they appeared as hypoattenuated or isoattenuated masses on computed tomography with hyperintense signal on T2-weighted magnetic resonance imaging. Intralesional hypointense septa were present in most cases. Of the 40 tumors, 30 belonged to the classic subtype, whereas 9 cases were cellular, and 1 case had a rhabdoid phenotype. Tumor cells showed variable expression of synaptophysin (36%), S-100 protein (29%), epithelial membrane antigen (11%), and neuron-specific enolase (7%). Ki-67 index was remarkably higher in the cellular variant (mean, 30%). EWSR1-related rearrangement was detected in 12 of 14 cases tested by fluorescence in situ hybridization using break-apart probes. The overall 5- and 7-year survival was 71% and 60%, respectively. Awareness of the imaging features may help pathologists in the diagnosis of EMC. Fluorescence in situ hybridization also serves as a useful diagnostic tool for EMC, especially in the distinction from its mimics.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Extraskeletal myxoid chondrosarcoma; Fluorescent in situ hybridization; Prognostic factor; Radiology

Mesh:

Substances:

Year:  2016        PMID: 27402218     DOI: 10.1016/j.anndiagpath.2016.04.004

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  7 in total

1.  INSM1 expression and its diagnostic significance in extraskeletal myxoid chondrosarcoma.

Authors:  Akihiko Yoshida; Naohiro Makise; Susumu Wakai; Akira Kawai; Nobuyoshi Hiraoka
Journal:  Mod Pathol       Date:  2018-01-12       Impact factor: 7.842

2.  Primary intracranial extraskeletal myxoid chondrosarcoma: A case report and review of literature.

Authors:  Zi-You Zhu; Yu-Bo Wang; Han-Yi Li; Xin-Min Wu
Journal:  World J Clin Cases       Date:  2022-05-06       Impact factor: 1.534

3.  Extraskeletal Myxoid Chondrosarcoma: A Comparative Study of Imaging and Pathology.

Authors:  Ling Zhang; Ruoning Wang; Rong Xu; Genggeng Qin; Lei Yang
Journal:  Biomed Res Int       Date:  2018-06-07       Impact factor: 3.411

4.  Extraskeletal Myxoid Chondrosarcoma: Clinical and Molecular Characteristics and Outcomes of Patients Treated at Two Institutions.

Authors:  Benedetta Chiusole; Axel Le Cesne; Marco Rastrelli; Marco Maruzzo; Martina Lorenzi; Rocco Cappellesso; Paolo Del Fiore; Silvia Imbevaro; Marta Sbaraglia; Philippe Terrier; Pietro Ruggieri; Angelo Paolo Dei Tos; Carlo Riccardo Rossi; Vittorina Zagonel; Antonella Brunello
Journal:  Front Oncol       Date:  2020-06-16       Impact factor: 6.244

5.  Low-Grade Chondrosarcoma In The Sellar Area: Case Report And Literature Review.

Authors:  Zhen Zhang; Li-Juan Pang; Ning Wang; Zhong Li; Yu-Wen Cao; Wen-Hao Hu; Wei-Hua Liang; Jin-Fang Jiang; Hong Zou; Yan Qi
Journal:  Onco Targets Ther       Date:  2019-12-10       Impact factor: 4.147

6.  Identification of Novel PGR-NR4A3 Fusion in Extraskeletal Myxoid Chondrosarcoma and Resultant Patient Benefit From Tamoxifen Therapy.

Authors:  H Catherine Wilbur; Dan R Robinson; Yi-Mi Wu; Chandan Kumar-Sinha; Arul M Chinnaiyan; Rashmi Chugh
Journal:  JCO Precis Oncol       Date:  2022-08

7.  Extraskeletal Myxoid Chondrosarcoma of the Parotid Gland.

Authors:  Nyimi Bushabu Fidele; Wu Tianfu; Bing Liu; Yanfang Sun; Zhao Yifang
Journal:  Ann Maxillofac Surg       Date:  2019 Jul-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.